This hypothesis is in accordance with mH2A role inhibiting certain types of cancer progression33–35 that is supposed to be due to, at least in part, cell cycle G1/S transition inhibition via regulation of CDKs (CDK 4, 6 and 8) and cyclins (Cyclin D1 and D2)36. Here, CCNL2 is linked to cancer.